ACME Laboratories (DHA:ACMELAB) Moat Score: 0/10 (As of Jul. 09, 2026)


DHA:ACMELAB ACME Laboratories Ltd DHA:ACMELAB
90 GF Score
Price BDT84.20
GF Value BDT125.40
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is ACME Laboratories Moat Score?

ACME Laboratories has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

ACME Laboratories has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes ACME Laboratories might have No Moat - No discernible moat.

ACME Laboratories  (DHA:ACMELAB) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

ACME Laboratories Moat Score Related Terms

DHA:ACMELAB
90GF Score
ACME Laboratories Ltd DHA:ACMELAB
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ACME Laboratories (DHA:ACMELAB) Overvalued in 2026?

Based on GuruFocus' analysis, ACME Laboratories stock appears to be undervalued. The current stock price of BDT84.20 is trading 32.9% below its estimated GF Value™ of BDT125.40. GuruFocus considers ACME Laboratories to be Possible Value Trap.

Key valuation signals for DHA:ACMELAB:

  • Moat Score: 0
  • GF Value™: BDT125.40 vs. price of BDT84.20 (32.9% below fair value)
  • GF Score™: 90/100 with 7 warning signs

No single metric tells the full story. See the DHA:ACMELAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ACME Laboratories Business Description

Address 1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The Company is engaged in manufacturing, marketing, and distribution of generic pharmaceuticals formulation products which includes human drugs comprising dosages form like a tablet, capsule, dry syrup, cream, ointment, powder, injection, dry powder inhaler, metered dosage inhaler, suppository, eye and nasal drop, liquid, liquid in hard gelatine, Blow Fill Seal (BFS) products, sachet products; veterinary drugs comprising dosages form like bolus, liquid,injection, water-soluble powder, premix and herbal drugs comprising dosages form like liquid, capsule, tablet, cream. The products of the company are sold in domestic and international markets.
90GF Score

Get the complete analysis for DHA:ACMELAB

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT84.20
Price
BDT125.40
GF Value